» Articles » PMID: 35268029

Reduced Kidney Function Is Associated with Increasing Red Blood Cell Folate Concentration and Changes in Folate Form Distributions (NHANES 2011-2018)

Overview
Journal Nutrients
Date 2022 Mar 10
PMID 35268029
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Current studies examining the effects of high concentrations of red blood cell (RBC) or serum folates assume that high folate concentrations are an indicator of high folic acid intakes, often ignoring the contributions of other homeostatic and biological processes, such as kidney function. Objective: The current study examined the relative contributions of declining kidney function, as measured by the risk of chronic kidney disease (CKD), and usual total folic acid intake on the concentrations of RBC folate and serum folate (total as well as individual folate forms). Design: Cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) collected in 2-year cycles were combined from 2011 to 2018. A total of 18,127 participants aged ≥16 years with available folate measures, kidney biomarker data (operationalized as a categorical CKD risk variable describing the risk of progression), and reliable dietary recall data were analyzed. Results: RBC folate concentrations increased as CKD risk increased: low risk, 1089 (95% CI: 1069, 1110) nmol/L; moderate risk, 1189 (95% CI: 1158, 1220) nmol/L; high risk, 1488 (95% CI: 1419, 1561) nmol/L; and highest risk, 1443 (95% CI: 1302, 1598) nmol/L (p < 0.0001). Similarly, serum total folate concentrations increased as CKD risk increased: low risk: 37.1 (95% CI: 26.3, 38.0) nmol/L; moderate risk: 40.2 (95% CI: 38.8, 41.7) nmol/L; high risk: 48.0 (95% CI: 44.3, 52.1) nmol/L; the highest Risk: 42.8 (95% CI: 37.8, 48.4) nmol/L (p < 0.0001). The modeled usual intake of folic acid showed no difference among CKD risk groups, with a population median of 225 (interquartile range: 108−390) µg/day. Conclusion: Both RBC and serum folate concentrations increased with declining kidney function without increased folic acid intake. When analyzing associations between folate concentrations and disease outcomes, researchers may want to consider the confounding role of kidney function.

Citing Articles

Association between RBC folate and diabetic nephropathy in Type2 diabetes mellitus patients: a cross-sectional study.

Yu P, Ji Y, Wang H, Liu K Sci Rep. 2024; 14(1):24692.

PMID: 39433832 PMC: 11494071. DOI: 10.1038/s41598-024-76456-0.


Distribution and correlates of plasma folate, vitamin B12, and homocysteine in a sample of low-income minority children aged 6 months to 9 years in the U.S.

Chen Y, Che X, Raghavan R Precis Nutr. 2024; 3(2).

PMID: 38899042 PMC: 11185822.


Folate and vitamin B12 usual intake and biomarker status by intake source in United States adults aged ≥19 y: NHANES 2007-2018.

Zhou Y, Wang A, Yeung L, Qi Y, Pfeiffer C, Crider K Am J Clin Nutr. 2023; 118(1):241-254.

PMID: 37172826 PMC: 10926004. DOI: 10.1016/j.ajcnut.2023.05.016.


Estimating the serum folate concentration that corresponds to the red blood cell folate concentration threshold associated with optimal neural tube defects prevention: A population-based biomarker survey in Southern India.

Fothergill A, Crider K, Rose C, Bose B, Guetterman H, Johnson C Am J Clin Nutr. 2023; 117(5):985-997.

PMID: 37137617 PMC: 10356561. DOI: 10.1016/j.ajcnut.2023.01.016.


Complete genome analysis of derived from yaks and its probiotic characteristics.

Li A, Wang M, Zhang Y, Lin Z, Xu M, Wang L Front Vet Sci. 2023; 9:1099150.

PMID: 36713867 PMC: 9875379. DOI: 10.3389/fvets.2022.1099150.


References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

2.
Fazili Z, Sternberg M, Potischman N, Wang C, Storandt R, Yeung L . Demographic, Physiologic, and Lifestyle Characteristics Observed with Serum Total Folate Differ Among Folate Forms: Cross-Sectional Data from Fasting Samples in the NHANES 2011-2016. J Nutr. 2019; 150(4):851-860. PMC: 7138665. DOI: 10.1093/jn/nxz278. View

3.
Delgado C, Baweja M, Crews D, Eneanya N, Gadegbeku C, Inker L . A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. J Am Soc Nephrol. 2021; 32(12):2994-3015. PMC: 8638402. DOI: 10.1681/ASN.2021070988. View

4.
Lowrance W, Ordonez J, Udaltsova N, Russo P, Go A . CKD and the risk of incident cancer. J Am Soc Nephrol. 2014; 25(10):2327-34. PMC: 4178430. DOI: 10.1681/ASN.2013060604. View

5.
Bailey L, Stover P, McNulty H, Fenech M, Gregory 3rd J, Mills J . Biomarkers of Nutrition for Development-Folate Review. J Nutr. 2015; 145(7):1636S-1680S. PMC: 4478945. DOI: 10.3945/jn.114.206599. View